These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 31505717

  • 21. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.
    Wiesener MS, Münchenhagen PM, Berger I, Morgan NV, Roigas J, Schwiertz A, Jürgensen JS, Gruber G, Maxwell PH, Löning SA, Frei U, Maher ER, Gröne HJ, Eckardt KU.
    Cancer Res; 2001 Jul 01; 61(13):5215-22. PubMed ID: 11431362
    [Abstract] [Full Text] [Related]

  • 22. Hypoxia-inducible factor-2α stabilizes the von Hippel-Lindau (VHL) disease suppressor, Myb-related protein 2.
    Okumura F, Joo-Okumura A, Nakatsukasa K, Kamura T.
    PLoS One; 2017 Jul 01; 12(4):e0175593. PubMed ID: 28394947
    [Abstract] [Full Text] [Related]

  • 23. Expression of von Hippel Lindau (pVHL) protein in placentae from normal pregnant women and women with preeclampsia.
    Rajakumar A, Doty K, Daftary A, Markovic N, Conrad KP.
    Placenta; 2006 Jul 01; 27(4-5):411-21. PubMed ID: 15955559
    [Abstract] [Full Text] [Related]

  • 24. TGFBI-promoted adhesion, migration and invasion of human renal cell carcinoma depends on inactivation of von Hippel-Lindau tumor suppressor.
    Shang D, Liu Y, Yang P, Chen Y, Tian Y.
    Urology; 2012 Apr 01; 79(4):966.e1-7. PubMed ID: 22341602
    [Abstract] [Full Text] [Related]

  • 25. Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations.
    Pollard PJ, El-Bahrawy M, Poulsom R, Elia G, Killick P, Kelly G, Hunt T, Jeffery R, Seedhar P, Barwell J, Latif F, Gleeson MJ, Hodgson SV, Stamp GW, Tomlinson IP, Maher ER.
    J Clin Endocrinol Metab; 2006 Nov 01; 91(11):4593-8. PubMed ID: 16954163
    [Abstract] [Full Text] [Related]

  • 26. Renal cancer cells lacking hypoxia inducible factor (HIF)-1alpha expression maintain vascular endothelial growth factor expression through HIF-2alpha.
    Shinojima T, Oya M, Takayanagi A, Mizuno R, Shimizu N, Murai M.
    Carcinogenesis; 2007 Mar 01; 28(3):529-36. PubMed ID: 16920734
    [Abstract] [Full Text] [Related]

  • 27. Expression of HIF-1 and ubiquitin in conventional renal cell carcinoma: relationship to mutations of the von Hippel-Lindau tumor suppressor gene.
    Hughson MD, He Z, Liu S, Coleman J, Shingleton WB.
    Cancer Genet Cytogenet; 2003 Jun 01; 143(2):145-53. PubMed ID: 12781449
    [Abstract] [Full Text] [Related]

  • 28. Expression of VHL and HIF-1α and Their Clinicopathologic Significance in Benign and Malignant Lesions of the Gallbladder.
    Yang Z, Yang Z, Xiong L, Huang S, Liu J, Yang L, Miao X.
    Appl Immunohistochem Mol Morphol; 2011 Dec 01; 19(6):534-9. PubMed ID: 21415706
    [Abstract] [Full Text] [Related]

  • 29. Increased hypoxic proliferative response and gene expression in erythroid progenitor cells of Andean highlanders with chronic mountain sickness.
    Bermudez D, Azad P, Figueroa-Mujíca R, Vizcardo-Galindo G, Corante N, Guerra-Giraldez C, Haddad GG, Villafuerte FC.
    Am J Physiol Regul Integr Comp Physiol; 2020 Jan 01; 318(1):R49-R56. PubMed ID: 31617751
    [Abstract] [Full Text] [Related]

  • 30. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas.
    Na X, Wu G, Ryan CK, Schoen SR, di'Santagnese PA, Messing EM.
    J Urol; 2003 Aug 01; 170(2 Pt 1):588-92. PubMed ID: 12853836
    [Abstract] [Full Text] [Related]

  • 31. EPAS1 regulates proliferation of erythroblasts in chronic mountain sickness.
    Liu H, Tang F, Su J, Ma J, Qin Y, Ji L, Geng H, Wang S, Zhang P, Liu J, Cui S, Ge RL, Li Z.
    Blood Cells Mol Dis; 2020 Sep 01; 84():102446. PubMed ID: 32470757
    [Abstract] [Full Text] [Related]

  • 32. Inactivation of von Hippel-Lindau increases ovarian cancer cell aggressiveness through the HIF1α/miR-210/VMP1 signaling pathway.
    Liu T, Zhao L, Chen W, Li Z, Hou H, Ding L, Li X.
    Int J Mol Med; 2014 May 01; 33(5):1236-42. PubMed ID: 24549370
    [Abstract] [Full Text] [Related]

  • 33. Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation.
    Turner KJ, Moore JW, Jones A, Taylor CF, Cuthbert-Heavens D, Han C, Leek RD, Gatter KC, Maxwell PH, Ratcliffe PJ, Cranston D, Harris AL.
    Cancer Res; 2002 May 15; 62(10):2957-61. PubMed ID: 12019178
    [Abstract] [Full Text] [Related]

  • 34. Differential regulation of LncRNA-SARCC suppresses VHL-mutant RCC cell proliferation yet promotes VHL-normal RCC cell proliferation via modulating androgen receptor/HIF-2α/C-MYC axis under hypoxia.
    Zhai W, Sun Y, Jiang M, Wang M, Gasiewicz TA, Zheng J, Chang C.
    Oncogene; 2016 Sep 15; 35(37):4866-80. PubMed ID: 26973243
    [Abstract] [Full Text] [Related]

  • 35. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein.
    Tanimoto K, Makino Y, Pereira T, Poellinger L.
    EMBO J; 2000 Aug 15; 19(16):4298-309. PubMed ID: 10944113
    [Abstract] [Full Text] [Related]

  • 36. Fibrosis and hypoxia-inducible factor-1α-dependent tumors of the soft tissue on loss of von Hippel-Lindau in mesenchymal progenitors.
    Mangiavini L, Merceron C, Araldi E, Khatri R, Gerard-O'Riley R, Wilson TL, Sandusky G, Abadie J, Lyons KM, Giaccia AJ, Schipani E.
    Am J Pathol; 2015 Nov 15; 185(11):3090-101. PubMed ID: 26348575
    [Abstract] [Full Text] [Related]

  • 37. Silencing of epidermal growth factor receptor suppresses hypoxia-inducible factor-2-driven VHL-/- renal cancer.
    Smith K, Gunaratnam L, Morley M, Franovic A, Mekhail K, Lee S.
    Cancer Res; 2005 Jun 15; 65(12):5221-30. PubMed ID: 15958567
    [Abstract] [Full Text] [Related]

  • 38. hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer.
    Camps C, Buffa FM, Colella S, Moore J, Sotiriou C, Sheldon H, Harris AL, Gleadle JM, Ragoussis J.
    Clin Cancer Res; 2008 Mar 01; 14(5):1340-8. PubMed ID: 18316553
    [Abstract] [Full Text] [Related]

  • 39. Differential effects of HIF-α isoforms on apoptosis in renal carcinoma cell lines.
    Doonachar A, Gallo MD, Doukas D, Pasricha R, Lantsberg I, Schoenfeld AR.
    Cancer Cell Int; 2015 Mar 01; 15():23. PubMed ID: 25729330
    [Abstract] [Full Text] [Related]

  • 40. Role of the von Hippel-Lindau tumour suppressor protein in the regulation of HIF-1alpha and its oxygen-regulated transactivation domains at high cell density.
    Paltoglou SM, Roberts BJ.
    Oncogene; 2005 May 26; 24(23):3830-5. PubMed ID: 15750626
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.